4.6 Article

Isolation of SARS-CoV-2 B.1.1.28.2 (P2) variant and pathogenicity comparison with D614G variant in hamster model

Journal

JOURNAL OF INFECTION AND PUBLIC HEALTH
Volume 15, Issue 2, Pages 164-171

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.jiph.2021.12.009

Keywords

SARS-CoV-2; B; 1; 28; 2; P2 variant; India; Pathogenicity

Funding

  1. Department of Health Research, Ministry of Health & Family Welfare, New Delhi
  2. Indian Council of Medical Research, New Delhi

Ask authors/readers for more resources

A variant known as B.1.1.28.2 has been identified from international travelers returning to India from the United Kingdom and Brazil. In a hamster model, the B.1.1.28.2 variant caused weight loss, viral replication in the respiratory tract, and severe lung pathology compared to the B.1 variant. Furthermore, sera from hamsters infected with B.1.1.28.2 efficiently neutralized the D614G variant virus, while a 6-fold reduction in neutralization was observed in sera from hamsters infected with the D614G variant against the B.1.1.28.2 variant.
Background: Considering the potential threat from emerging Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2) variants and the rising COVID-19 cases, SARS-CoV-2 genomic surveillance is ongoing in India. We report herewith the isolation of the P.2 variant (B.1.1.28.2) from international travelers and further its pathogenicity evaluation and comparison with D614G variant (B.1) in hamster model. Methods: Virus isolation was performed in Vero CCL81 cells and genomic characterization by next generation sequencing. The pathogenicity and host immune response of the isolate was assessed in Syrian hamster model and compared with B.1 variant. Results: B.1.1.28.2 variant was isolated from nasal/throat swabs of international travelers returned to India from United Kingdom and Brazil. The B.1.1.28.2 variant induced body weight loss, viral replication in the respiratory tract and caused severe lung pathology in infected Syrian hamster model in comparison, with B.1 variant infected hamsters. The sera from B.1.1.28.2 infected hamsters efficiently neutralized the D614G variant virus whereas 6-fold reduction in the neutralization was seen in case of D614G variant infected hamsters' sera with the B.1.1.28.2 variant. Conclusions: B.1.1.28.2 lineage variant could be successfully isolated and characterization could be performed. Pathogenicity of the isolate was demonstrated in Syrian hamster model and the findings of neutralization reduction is of great concern and point towards the need for screening the vaccines for efficacy.(c) 2021 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available